N/A N=238 Personalized Risk Estimator for Rheumatoid Arthritis Family Study
First Degree Relatives of Rheumatoid Arthritis Patients
Primary: Contemplation Ladder — 40; 46; 43; 41 Participants — p=0.043
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=101 Cardiovascular Risk Assessment for Patients With Rheumatoid Arthritis Arthritis:
Rheumatoid Arthritis · Cardiovascular Diseases · Hyperlipidemias
Primary: Number of Subjects With Lipids Checked (Available Now Through National Laboratory Chain) or That Reported Having Their Lipids Checked by Their 1-week or 3-month Visit…
N/A N=278 Clinical Follow-up of Anti-Carbamylated Antibody Status in Rheumatoid Arthritis
RheumatoId Arthritis
Primary: DAS28-ESR — 3.75; 3.72; 3.59; 3.69 units on a scale — p=0.82
N/A N=200 Depression and Anxiety in Rheumatoid Arthritis
Rheumatoid Arthritis · Depression · Anxiety
Primary: Hospital Anxiety and Depression Scale (HADS) — 107; 46; 20; 27 participants
N/A N=178 Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA)
Rheumatoid Arthritis · Psoriatic Arthritis · Periodontal Disease
Primary: Alteration of Microbiota, Alteration of T Cell Function/Activation — 4; 10; 2; 0 participants
N/A N=125 Autoantibodies to Gastric Parietal Cells in Rheumatoid Arthritis Patients
Vitamin B12 Deficiency
Primary: Prevalence of Vitamin B12 Deficiency — 3; 6; 4 participants
Phase 4 N=149 RHYTHM (Formerly Escape II Myocardium)
Rheumatoid Arthritis
Primary: Number of Participants With Myocardial FDG Uptake — 21; 4; 25; 1 Participants
N/A N=286 Prevalence of Dry Eye Disease in Patients Diagnosed With Rheumatoid Arthritis
Dry Eye Syndromes · Rheumatoid Arthritis
Primary: Number of Participants Diagnosed With Rheumatoid Arthritis Also Found to Have Dry Eye Disease — 275 participants
N/A N=356 Time to DMARD (Disease-Modifying Anti-Rheumatic Drug) Treatment and Actual Work Limitation of Patients With Rheumatoid Arthritis in Turkey
Rheumatoid Arthritis
Primary: Evaluation of Disease Duration: Time From Diagnosis to Disease-Modifying Anti-Rheumatic Drug Treatment in Rheumatoid Arthritis — 11.7177 Months
Phase 2 N=56 Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients
Arthritis, Rheumatoid
Primary: Number of Participants With a Diagnosis of Rheumatoid Arthritis (RA) by American Rheumatism Association (ARA) Criteria and/or Discontinued Due to Lack of Efficacy — 12…
N/A N=1,493 Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients
Arthritis, Rheumatoid
Primary: Disease Activity Score 28 (DAS28) in Participants With Positive Rheumatoid Factor (RF) and Anti-Cyclic Citrullinated Peptide (ACCP) at Last Follow-up Visit (Month 12)…
Phase 3 N=10 Rituximab in Rheumatoid Arthritis Lung Disease
Rheumatoid Arthritis · Interstitial Pneumonia
Primary: Change in Diffusion Capacity for Carbon Monoxide (DLco) From Baseline to 48 Weeks — 4; 2; 1 participants
Phase 3 N=143 PPAR-gamma Agonists, Rheumatoid Arthritis and Cardiovascular Disease
Rheumatoid Arthritis
Primary: Brachial Artery Diameter Change From Baseline in Response to Reactive Hyperemia — 8.3; 9.43 % changes in diameter of artery
Phase 4 N=27 IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA
Rheumatoid Arthritis
Primary: IL-7 and IL-7R Expression in Peripheral Blood Mononuclear Cells of RA Patients With Active vs. Inactive Disease Treated With DMARD and/or CIMZIA. — 0.700; 1.330; 0.777…
N/A N=128 Inflammation and the Heart
Rheumatoid Arthritis
Primary: Left Ventricular Mass Indexed to BSA, g/m^2 — 43.8; 42.2 g/m^2
N/A N=125 "Learning About Biologics"-Rheumatoid Arthritis
Rheumatoid Arthritis
Primary: The Proportion of Subjects Who Are Classified as Having Made an Informed Value Concordant Choice at 2 Weeks — 32; 13 Percentage of subjects
N/A N=18 Ultrasound Efficacy in Moderate Rheumatoid Arthritis
Rheumatoid Arthritis
Primary: Low Synovitis Scores — 1 Participants
N/A N=20 Cardiovascular Risk Markers in Patients With Rheumatoid Arthritis: Effect of Rituximab Therapy
Endothelial Function · Rheumatoid Arthritis · Inflammation
Primary: Flow-mediated Vasodilation (FMD) — 6.1; 4.4 percentage change in diameter
N/A N=13,182 Comorbidities and Outcomes in Early Rheumatoid Arthritis
Rheumatoid Arthritis
Primary: Event Rate for a Cardiovascular Composite of Incident Myocardial Infarction, Stroke, or Heart Failure — 10.62; 8.13 Events per 1000 person years
N/A N=353 Rheumatoid Arthritis: Comparison of Active Therapies in Patients With Active Disease Despite Methotrexate Therapy
Rheumatoid Arthritis
Primary: Mean 48-week Change in DAS28 — -2.12; -2.29 units on a scale
N/A N=79 Living Well With Rheumatoid Arthritis
Rheumatoid Arthritis
Primary: RADAI Disease Activity Score — -0.4; 0.1 units on a scale — p=0.04
N/A N=109 N-3 PUFA and Rheumatoid Arthritis in Korea
Rheumatoid Arthritis
Primary: Dose of NSAID — 319.72; 301.58 mg
Phase 3 N=511 Remission and Joint Damage Progression in Early Rheumatoid Arthritis
Rheumatoid Arthritis
Primary: Number of Participants in DAS 28 C-reactive Protein (CRP) Remission at Month 12 — 106; 59 participants — p=<0.001
N/A N=20 Sleep and Immunity in Rheumatoid Arthritis : Remicade Substudy
Rheumatoid Arthritis
Primary: Slow Wave Sleep — 82.6; 67.3 Minutes
N/A N=18 Dietary Salt in Rheumatoid Arthritis
Rheumatoid Arthritis
Primary: Change in Tissue Sodium — 17.1; 16.7 mmol/L — p=0.55
N/A N=808 An Observational Study to Describe in Routine Clinical Practice the Treatment Patterns of Usage of Biological DMARDs in RA Patients.
Rheumatoid Arthritis
Primary: Number of Participants Receiving Biological Agent as Monotherapy or in Combination With Conventional Synthesis Disease-modifying Anti-rheumatic Drugs (csDMARDs) Therapy…
N/A N=34 Inflammation and Insulin Resistance in Rheumatoid Arthritis
Rheumatoid Arthritis
Primary: Disease Activity Score Based on 28-joint Disease Activity Score (DAS28) — 4.40; 4.03; 4.57; 4.48 units on a scale
N/A N=209 An Observational Study in Clinical Practice Management of Patients With Biological Drugs in Monotherapy
Rheumatoid Arthritis
Primary: Number of Participants With Level of Education Completed — 01; 15; 86; 59 Participants
N/A N=363 A Feasibility Study Exploring the Effect of Remicade on the Disease Activity in RA Patients (Study P05417)
Rheumatoid Arthritis
Primary: Dosing Interval Between the Infliximab Infusions — 121; 205; 37 participants
N/A N=224 Effects of a Rheumatoid Arthritis Self-management Program
Arthritis, Rheumatoid
Primary: Disease Activity — 3.38; 3.62 score on a scale